EpiStem Holdings plc
02 November 2007
EpiStem Holdings plc
2 November 2007
EpiStem Holdings plc (the 'Company') was informed on 31 October by IS Partners
Investment Solutions AG as advisors to the Helium Special Situations Fund (the
'Fund'), that the Fund has increased its shareholdings in the Company from
420,600 to 513,100 ordinary shares. This increase came through several recent
purchases. As a consequence the Fund now holds 7.85% of the issued share capital
of the Company, up from 6.43% previously.
Contacts:
EpiStem Holdings Plc:
Matthew Walls (CEO)
Tel: 0161 606 7263
John Rylands (Financial Director and Company Secretary)
Tel: 0161 606 7258
Landsbanki Securities (UK) Limited:
Thilo Hoffmann/Simon Brown
Tel: 020 7426 9000
MC Bio-Communications Limited:
Mike Wort
Tel: 020 7744 7711
This information is provided by RNS
The company news service from the London Stock Exchange

